194 related articles for article (PubMed ID: 31580238)
1. Nonalcoholic Steatohepatitis Is the Most Rapidly Growing Indication for Liver Transplantation in Iranian Patients.
Eshraghian A; Nikeghbalian S; Dehghani M; Shamsaeefar A; Kazemi K; Nikoopour H; Eghlimi H; Gholami S; Salahi H; Malek-Hosseini SA
Exp Clin Transplant; 2022 May; 20(5):487-494. PubMed ID: 31580238
[TBL] [Abstract][Full Text] [Related]
2. A Single-Center Study of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Recurrence in Recipients of Liver Transplant for Treatment of Nonalcoholic Steatohepatitis Cirrhosis.
Matsuoka L; Chotai PN; Slaughter J; Campbell K; Kerr A; Hamel S; Garza C; Alexopoulos SP; Scanga A
Exp Clin Transplant; 2022 Feb; 20(2):150-156. PubMed ID: 35037605
[TBL] [Abstract][Full Text] [Related]
3. Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis.
Piazza NA; Singal AK
Exp Clin Transplant; 2016 Feb; 14(1):79-85. PubMed ID: 26581602
[TBL] [Abstract][Full Text] [Related]
4. Increasing prevalence of nonalcoholic steatohepatitis as an indication for liver transplantation.
Quillin RC; Wilson GC; Sutton JM; Hanseman DJ; Paterno F; Cuffy MC; Paquette IM; Diwan TS; Woodle ES; Abbott DE; Shah SA
Surgery; 2014 Oct; 156(4):1049-56. PubMed ID: 25239365
[TBL] [Abstract][Full Text] [Related]
5. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
Cholankeril G; Wong RJ; Hu M; Perumpail RB; Yoo ER; Puri P; Younossi ZM; Harrison SA; Ahmed A
Dig Dis Sci; 2017 Oct; 62(10):2915-2922. PubMed ID: 28744836
[TBL] [Abstract][Full Text] [Related]
6. Management of Recurrent and De Novo NAFLD/NASH After Liver Transplantation.
Germani G; Laryea M; Rubbia-Brandt L; Egawa H; Burra P; OʼGrady J; Watt KD
Transplantation; 2019 Jan; 103(1):57-67. PubMed ID: 30335694
[TBL] [Abstract][Full Text] [Related]
7. Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges.
Samji NS; Verma R; Keri KC; Singal AK; Ahmed A; Rinella M; Bernstein D; Abdelmalek MF; Satapathy SK
Dig Dis Sci; 2019 Dec; 64(12):3413-3430. PubMed ID: 31312990
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic Steatohepatitis is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States.
Singal AK; Hasanin M; Kaif M; Wiesner R; Kuo YF
Transplantation; 2016 Mar; 100(3):607-12. PubMed ID: 26479282
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation.
Younossi ZM
Liver Transpl; 2018 Feb; 24(2):166-170. PubMed ID: 29272073
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic fatty liver disease after liver transplantation in patients with non-alcoholic steatohepatitis and cryptogenic cirrhosis: the impact of pre-transplant graft steatosis.
Eshraghian A; Nikeghbalian S; Kazemi K; Shamsaeefar A; Geramizadeh B; Malek-Hosseini SA
HPB (Oxford); 2020 Apr; 22(4):521-528. PubMed ID: 31431413
[TBL] [Abstract][Full Text] [Related]
11. The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study.
Unger LW; Herac M; Staufer K; Salat A; Silberhumer G; Hofmann M; Trauner M; Rasoul-Rockenschaub S; Soliman T; Reiberger T; Berlakovich GA
Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):309-316. PubMed ID: 27922486
[TBL] [Abstract][Full Text] [Related]
12. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
[TBL] [Abstract][Full Text] [Related]
13. High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.
Kern B; Feurstein B; Fritz J; Fabritius C; Sucher R; Graziadei I; Bale R; Tilg H; Zoller H; Newsome P; Eschertzhuber S; Margreiter R; Öfner D; Schneeberger S
Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):205-210. PubMed ID: 30320609
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries.
Holmer M; Melum E; Isoniemi H; Ericzon BG; Castedal M; Nordin A; Aagaard Schultz N; Rasmussen A; Line PD; Stål P; Bennet W; Hagström H
Liver Int; 2018 Nov; 38(11):2082-2090. PubMed ID: 29630771
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic steatohepatitis: the new frontier for liver transplantation.
Bzowej NH
Curr Opin Organ Transplant; 2018 Apr; 23(2):169-174. PubMed ID: 29356708
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times.
Gitto S; Marra F; De Maria N; Bihl F; Villa E; Andreone P; Burra P
Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):173-178. PubMed ID: 30791778
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation.
Carter D; Dieterich DT; Chang C
Clin Liver Dis; 2018 Feb; 22(1):213-227. PubMed ID: 29128058
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
Mikolasevic I; Filipec-Kanizaj T; Mijic M; Jakopcic I; Milic S; Hrstic I; Sobocan N; Stimac D; Burra P
World J Gastroenterol; 2018 Apr; 24(14):1491-1506. PubMed ID: 29662288
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease: a systematic review.
Rinella ME
JAMA; 2015 Jun; 313(22):2263-73. PubMed ID: 26057287
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation and non-alcoholic fatty liver disease.
Zezos P; Renner EL
World J Gastroenterol; 2014 Nov; 20(42):15532-8. PubMed ID: 25400437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]